(Q51806468)

12 April 2018

title

Regulation of the CD56 promoter and its association with proliferation, anti-apoptosis and clinical factors in multiple myeloma. (English)

1 reference

12 April 2018

author name string

Tina Damgaard

1

1 reference

12 April 2018

Lene M Knudsen

2

1 reference

12 April 2018

Inger Marie S Dahl

3

1 reference

12 April 2018

Peter Gimsing

4

1 reference

12 April 2018

Marianne Lodahl

5

1 reference

12 April 2018

Thomas Rasmussen

6

1 reference

12 April 2018

publication date

1 February 2009

1 reference

12 April 2018

published in

Leukemia & Lymphoma

1 reference

12 April 2018

volume

50

1 reference

12 April 2018

issue

2

1 reference

12 April 2018

page(s)

236-246

1 reference

12 April 2018

Chromosome translocations in multiple myeloma

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Advances in biology of multiple myeloma: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Prognostic significance of surface markers expressed in multiple myeloma: CD56 and other antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Localization of the human NCAM gene to band q23 of chromosome 11: the third gene coding for a cell interaction molecule mapped to the distal portion of the long arm of chromosome 11

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Molecular classification of multiple myeloma: a distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Commitment to the B-lymphoid lineage depends on the transcription factor Pax5

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Expression of PAX5 in CD20-positive multiple myeloma assessed by immunohistochemistry and oligonucleotide microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

C-MAF oncogene dysregulation in multiple myeloma: frequency and biological relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Occurrence of dysregulated oncogenes in primary plasma cells representing consecutive stages of myeloma pathogenesis: indications for different disease entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

A binding site for Pax proteins regulates expression of the gene for the neural cell adhesion molecule in the embryonic spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

MYND-less splice variants of AML1-MTG8 (RUNX1-CBFA2T1) are expressed in leukemia with t(8;21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

AML1 stimulates G1 to S progression via its transactivation domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

AML-1A and AML-1B regulation of MIP-1alpha expression in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Differential gene expression of the neural cell adhesion molecule (N-CAM) in a panel of multiple myeloma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Cyclin D1 induction through IkappaB kinase beta/nuclear factor-kappaB pathway is responsible for arsenite-induced increased cell cycle G1-S phase transition in human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Genomic organization, chromosomal localization, and independent expression of human cyclin D genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802699332

10.1080/10428190802699332

21 January 2018

Identifiers

DOI

1 reference

12 April 2018

PubMed ID

19235015

1 reference

12 April 2018